| 产品详情 |
| Edit |   |
| Product Name | EHNA (hydrochloride) |
| Description | Purity >98%. EHNA is a reversible adenosine deaminase inhibitor (IC50 = 1.2 µM in human red blood cells) that also selectively inhibits the cGMP-specific phosphodiesterase (PDE2) (IC50 s = 0.8 and 2 µM from human and porcine myocardium, respectively, 3.5 µM in rat hepatocyte, and 5.5 µM in human platelet). Comparatively, EHNA is much less potent at inhibiting PDE1, PDE3, or PDE4 (IC50 s > 100 µM). EHNA has been used to evaluate cardioprotective and neuroprotective effects during ischemia, to study the role of cAMP/cGMP signaling, and to maintain pluripotency/prevent differentiation of human embryonic stem cells. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | (aR,BetaS)-rel -6-amino-Beta-hexyl-a-methyl-9H-purine-9-ethanol, monohydrochloride, Erythro-9-(2-Hydroxy-3-nonyl)adenine, NSC 263164 |
| Gene, Accession, CAS # | CAS: 58337-38-5 |
| Catalog # | LS-H7630 |
| Price | |
| Order / More Info | EHNA (hydrochloride) from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|